Live Breaking News & Updates on Serious Disease

Stay updated with breaking news from Serious disease. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DOH investigating confirmed case of measles in unvaccinated Oahu resident

The Hawaii Department of Health is investigating a confirmed case of measles in an unvaccinated Oahu resident who returned from international travel. ....

United States , Sarah Kimble , Kenneth Fink , Hawaii Department Of Health , Centers For Disease , Hawaii Department , Medical Advisory , State Epidemiologist , Disease Control , Infectious Diseases , Medical Specialties , Epidemiology Of Measles , Measles Vaccine , Runny Nose , Nfected Person Coughs , Director Of Health , Vaccine Preventable Disease , Sarah Kimble , Department Of Health , Kenneth Fink , Healthcare Providers , Serious Disease , United States , Highly Contagious Disease , Enters For Disease Control And Prevention ,

Five Ways Men Can Take Charge of Their Health

While many of us procrastinate when it comes to our health, studies show men tend to resist medical care more than women. This June, as we celebrate Men’s Health Month, ....

United States , Ownership Of Your Health , Men Health Month , American Cancer Society , Health Month , Primary Care , Prostate Exam , American Cancer , Birth Control In The United States , Take Charge , Government Of Washington , Global Health , Health Communication , Global Mental Health , Heart Attacks , Dvocate For Yourself And Your Body , Olonoscopy Prostate Cancer , Chief Medical Officer , Serious Disease , J Pyke , United States , American Cancer Society , Prostate Cancer , Jackson North Medical Center , Arly Stage Cancers , Colon Cancer ,

First Subjects Randomized and Dosed in the U.S. under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OA

/PRNewswire/ Paradigm Biopharmaceuticals Ltd (ASX: PAR) ("Paradigm" or "the Company"), a clinical-stage biopharmaceutical company focused on repurposing. ....

Northwestern University , United States , United Kingdom , City Of , Thomasj Schnitzer , Donna Skerrett , Institute For Health , Master Of The American College Rheumatology , Paradigm Biopharmaceuticals , Prnewswire Paradigm Biopharmaceuticals Ltd , National Institutes Of Health , Drug Administration , Harvard Medical School , Northwestern University Feinberg School Of Medicine , Global Health Data Exchange , Office Of Clinical Research , University Of Washington , Imperial Cancer Research Institute , Biopharmaceuticals Ltd , Lead Investigator , Thomas Schnitzer , Chief Medical Officer , Patient Global Impression , Fast Track Designation , Physical Medicine , Northwestern University Feinberg School ,

US FDA Grants Fast Track Designation for Paradigm's Phase 3 Osteoarthritis Program

US FDA Grants Fast Track Designation for Paradigm’s Phase 3 Osteoarthritis ProgramFDA Fast Track Designation for Pentosan Polysulfate Sodium (Zilosul™/PPS) offers pathways to expedite development of Paradigm’s osteoarthritis clinicalFDA Fast Track acknowledges osteoarthritis as a serious disease wi. ....

United Kingdom , Donna Skerrett , University Of Accessed , Institute For Health , Paradigm Biopharmaceuticals Ltd , Paradigm Biopharmaceuticals , Osteoarthritis Program , Drug Administration , Global Health Data Exchange , Fast Track Designation , Track Designation , Pentosan Polysulfate Sodium , Biopharmaceuticals Ltd , Paradigm Chief Medical Officer , Health Data Exchange , Metrics Evaluation , Accessed June , Serious Disease , Drug Administration December , Patient Global Impression ,

FDA Grants Fast Track Designation for Paradigm Biopharmaceuticals Phase III Osteoarthritis Program

Approval demonstrates the potential of Zilosul™ to address an unmet medical need in OA which effects more than 72 million people in the US, EU5, and Canada KEY. ....

Donna Skerrett , Institute For Health , University Of Washington , Drug Administration , Fast Track Program , Global Health Data Exchange , Paradigm Chief Medical Officer , Fast Track Designation , Track Program , Paradigm Biopharmaceuticals , Pentosan Polysulfate Sodium , Metrics Evaluation , Accessed June , Serious Disease , Drug Administration December ,